Barely Significant
← all phrases

borderline significance

7,018 sentences · 7,018 papers · 11,270 search hits before verification

In the literature

borderline significancep = 0.0581.2× alpha
A significant inverse correlation of Gal-3 with DLCO% and KCO% was observed among CLAD-free, while Gal-9 showed inverse correlations with KCO% among stable patients, and with measured FVC in CLAD-BOS patients (the latter with borderline significance, but with a good Rho coefficient: − 0.714, p = 0.058) (Table 2 ).
borderline significancep = 0.0581.2× alpha
Subgroup analyses in high‐risk patients (i.e., those bearing T4 disease, N3 disease, or poor differentiation) revealed that a high NLR was a significant adverse risk factor for both OS and DC (all p < 0.03)—with a borderline significance being evident for DC in patients with T4 disease ( p = 0.058).
borderline significancep=0.0581.2× alpha
Komatsu et al 24 performed a matched cohort study of patients undergoing proton radiotherapy and those undergoing surgery at Kobe University, Japan; each arm had 19 patients with similar characteristics, except that there was a higher proportion of patients with Child-Pugh class A in the surgery arm, with borderline significance (89.5% vs 57.9%, p=0.058).
borderline significanceP = 0.0581.2× alpha
Even though none of these genetic polymorphisms significantly predicted tumor recurrence among these patients, EGFR:rs2227983, VEGF:rs2010963, and EGF:rs2237051 showed borderline significance for disease progression (P = 0.058 for EGFR:rs2227983, P = 0.073 for VEGF:rs2010963, and P = 0.104 for EGF:rs2237051; Table 2 ).
borderline significanceP = 0.0581.2× alpha
A significantly greater number of PDT was needed in the deferred combination group than that in the initial combination group ( P = 0.025, 2-sample t -test). The mean total number of anti-VEGF therapy on eyes with subtype 1 PCV was greater than that on eyes with subtype 2 PCV with borderline significance (6.75 vs 4.23, P = 0.058, 2-sample t -test).
borderline significancep -value = 0.0581.2× alpha
The survival analysis for rs1052133 shows a trend ( p -value = 0.058, borderline significance) with an OS increase of 15.02 months in the patients with genotype CC + CG versus the patients with the GG genotype (CC + CG: 113.00 months [95% CI 103.64 to 122.35 months] vs.